La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients

Identifieur interne : 000131 ( PascalFrancis/Corpus ); précédent : 000130; suivant : 000132

Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients

Auteurs : Abdul Qayyum Rana ; Ishraq Siddiqui ; Masood Zangeneh ; Abdul Fattah ; Naeem Awan ; Muhammad Saad Yousuf

Source :

RBID : Francis:13-0373166

Descripteurs français

English descriptors

Abstract

Aim: While much research has been conducted towards understanding the basis of visual hallucinations in Parkinson's disease, little has focused on characterizing the content and patients' emotional experience. These factors are likely very influential on a patient's decision to seek treatment, a critical aspect of any symptom from the clinical perspective. Methods: A retrospective chart analysis was performed on Parkinson's disease patients seen in a community-based Parkinson's Disease and Movement Disorder Clinic between 2005 and 2010. Results: The study consisted of 334 patients with Parkinson's disease, among whom 10.5% had visual hallucinations. Hoehn and Yahr disease stage (P = 0.001), concurrent presence of dementia (P = 0.001), and sex (P = 0.031) were significant onset predictors. The most significant determinant of treatment-seeking was emotional reaction, namely whether hallucinations were bothersome (P = 0.008). However, the specific type of content during hallucinations was sometimes more influential and contradicted emotional response. Conclusion: Although treatment-seeking can be predicted by how individuals feel about hallucinations, a patient's decision may not be logically consistent. We suggest that clinicians offer treatment based on patients' recollections and opinions.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 1323-1316
A03   1    @0 Psychiatry clin. neurosci. : (Carlton. Print)
A05       @2 67
A06       @2 7
A08 01  1  ENG  @1 Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients
A11 01  1    @1 QAYYUM RANA (Abdul)
A11 02  1    @1 SIDDIQUI (Ishraq)
A11 03  1    @1 ZANGENEH (Masood)
A11 04  1    @1 FATTAH (Abdul)
A11 05  1    @1 AWAN (Naeem)
A11 06  1    @1 SAAD YOUSUF (Muhammad)
A14 01      @1 Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre @3 CAN @Z 1 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut.
A14 02      @1 University of Toronto Scarborough @3 CAN @Z 2 aut. @Z 6 aut.
A14 03      @1 Factor-Inwentash Faculty of Social Work, University of Toronto @2 Toronto @3 CAN @Z 3 aut.
A20       @1 509-516
A21       @1 2013
A23 01      @0 ENG
A43 01      @1 INIST @2 2312 @5 354000504263120060
A44       @0 0000 @1 © 2013 INIST-CNRS. All rights reserved.
A45       @0 24 ref.
A47 01  1    @0 13-0373166
A60       @1 P
A61       @0 A
A64 01  1    @0 Psychiatry and clinical neurosciences : (Carlton. Print)
A66 01      @0 AUS
C01 01    ENG  @0 Aim: While much research has been conducted towards understanding the basis of visual hallucinations in Parkinson's disease, little has focused on characterizing the content and patients' emotional experience. These factors are likely very influential on a patient's decision to seek treatment, a critical aspect of any symptom from the clinical perspective. Methods: A retrospective chart analysis was performed on Parkinson's disease patients seen in a community-based Parkinson's Disease and Movement Disorder Clinic between 2005 and 2010. Results: The study consisted of 334 patients with Parkinson's disease, among whom 10.5% had visual hallucinations. Hoehn and Yahr disease stage (P = 0.001), concurrent presence of dementia (P = 0.001), and sex (P = 0.031) were significant onset predictors. The most significant determinant of treatment-seeking was emotional reaction, namely whether hallucinations were bothersome (P = 0.008). However, the specific type of content during hallucinations was sometimes more influential and contradicted emotional response. Conclusion: Although treatment-seeking can be predicted by how individuals feel about hallucinations, a patient's decision may not be logically consistent. We suggest that clinicians offer treatment based on patients' recollections and opinions.
C02 01  X    @0 770D03M @1 IV
C03 01  X  FRE  @0 Recherche aide @5 01
C03 01  X  ENG  @0 Help seeking @5 01
C03 01  X  SPA  @0 Busqueda ayuda @5 01
C03 02  X  FRE  @0 Traitement @5 02
C03 02  X  ENG  @0 Treatment @5 02
C03 02  X  SPA  @0 Tratamiento @5 02
C03 03  X  FRE  @0 Hallucination visuelle @2 NM @5 03
C03 03  X  ENG  @0 Visual hallucination @2 NM @5 03
C03 03  X  SPA  @0 Alucinación visual @2 NM @5 03
C03 04  X  FRE  @0 Maladie de Parkinson @2 NM @5 04
C03 04  X  ENG  @0 Parkinson disease @2 NM @5 04
C03 04  X  SPA  @0 Parkinson enfermedad @2 NM @5 04
C03 05  X  FRE  @0 Psychose @5 05
C03 05  X  ENG  @0 Psychosis @5 05
C03 05  X  SPA  @0 Psicosis @5 05
C03 06  X  FRE  @0 Homme @5 18
C03 06  X  ENG  @0 Human @5 18
C03 06  X  SPA  @0 Hombre @5 18
C07 01  X  FRE  @0 Pathologie de l'encéphale @5 37
C07 01  X  ENG  @0 Cerebral disorder @5 37
C07 01  X  SPA  @0 Encéfalo patología @5 37
C07 02  X  FRE  @0 Syndrome extrapyramidal @5 38
C07 02  X  ENG  @0 Extrapyramidal syndrome @5 38
C07 02  X  SPA  @0 Extrapiramidal síndrome @5 38
C07 03  X  FRE  @0 Maladie dégénérative @5 39
C07 03  X  ENG  @0 Degenerative disease @5 39
C07 03  X  SPA  @0 Enfermedad degenerativa @5 39
C07 04  X  FRE  @0 Pathologie du système nerveux central @5 40
C07 04  X  ENG  @0 Central nervous system disease @5 40
C07 04  X  SPA  @0 Sistema nervosio central patología @5 40
C07 05  X  FRE  @0 Pathologie du système nerveux @5 41
C07 05  X  ENG  @0 Nervous system diseases @5 41
C07 05  X  SPA  @0 Sistema nervioso patología @5 41
N21       @1 350
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : FRANCIS 13-0373166 INIST
ET : Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients
AU : QAYYUM RANA (Abdul); SIDDIQUI (Ishraq); ZANGENEH (Masood); FATTAH (Abdul); AWAN (Naeem); SAAD YOUSUF (Muhammad)
AF : Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre/Canada (1 aut., 4 aut., 5 aut., 6 aut.); University of Toronto Scarborough/Canada (2 aut., 6 aut.); Factor-Inwentash Faculty of Social Work, University of Toronto/Toronto/Canada (3 aut.)
DT : Publication en série; Niveau analytique
SO : Psychiatry and clinical neurosciences : (Carlton. Print); ISSN 1323-1316; Australie; Da. 2013; Vol. 67; No. 7; Pp. 509-516; Bibl. 24 ref.
LA : Anglais
EA : Aim: While much research has been conducted towards understanding the basis of visual hallucinations in Parkinson's disease, little has focused on characterizing the content and patients' emotional experience. These factors are likely very influential on a patient's decision to seek treatment, a critical aspect of any symptom from the clinical perspective. Methods: A retrospective chart analysis was performed on Parkinson's disease patients seen in a community-based Parkinson's Disease and Movement Disorder Clinic between 2005 and 2010. Results: The study consisted of 334 patients with Parkinson's disease, among whom 10.5% had visual hallucinations. Hoehn and Yahr disease stage (P = 0.001), concurrent presence of dementia (P = 0.001), and sex (P = 0.031) were significant onset predictors. The most significant determinant of treatment-seeking was emotional reaction, namely whether hallucinations were bothersome (P = 0.008). However, the specific type of content during hallucinations was sometimes more influential and contradicted emotional response. Conclusion: Although treatment-seeking can be predicted by how individuals feel about hallucinations, a patient's decision may not be logically consistent. We suggest that clinicians offer treatment based on patients' recollections and opinions.
CC : 770D03M
FD : Recherche aide; Traitement; Hallucination visuelle; Maladie de Parkinson; Psychose; Homme
FG : Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Pathologie du système nerveux
ED : Help seeking; Treatment; Visual hallucination; Parkinson disease; Psychosis; Human
EG : Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases
SD : Busqueda ayuda; Tratamiento; Alucinación visual; Parkinson enfermedad; Psicosis; Hombre
LO : INIST-2312.354000504263120060
ID : 13-0373166

Links to Exploration step

Francis:13-0373166

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients</title>
<author>
<name sortKey="Qayyum Rana, Abdul" sort="Qayyum Rana, Abdul" uniqKey="Qayyum Rana A" first="Abdul" last="Qayyum Rana">Abdul Qayyum Rana</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Siddiqui, Ishraq" sort="Siddiqui, Ishraq" uniqKey="Siddiqui I" first="Ishraq" last="Siddiqui">Ishraq Siddiqui</name>
<affiliation>
<inist:fA14 i1="02">
<s1>University of Toronto Scarborough</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zangeneh, Masood" sort="Zangeneh, Masood" uniqKey="Zangeneh M" first="Masood" last="Zangeneh">Masood Zangeneh</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Factor-Inwentash Faculty of Social Work, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Fattah, Abdul" sort="Fattah, Abdul" uniqKey="Fattah A" first="Abdul" last="Fattah">Abdul Fattah</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Awan, Naeem" sort="Awan, Naeem" uniqKey="Awan N" first="Naeem" last="Awan">Naeem Awan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Saad Yousuf, Muhammad" sort="Saad Yousuf, Muhammad" uniqKey="Saad Yousuf M" first="Muhammad" last="Saad Yousuf">Muhammad Saad Yousuf</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>University of Toronto Scarborough</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">13-0373166</idno>
<date when="2013">2013</date>
<idno type="stanalyst">FRANCIS 13-0373166 INIST</idno>
<idno type="RBID">Francis:13-0373166</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000131</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients</title>
<author>
<name sortKey="Qayyum Rana, Abdul" sort="Qayyum Rana, Abdul" uniqKey="Qayyum Rana A" first="Abdul" last="Qayyum Rana">Abdul Qayyum Rana</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Siddiqui, Ishraq" sort="Siddiqui, Ishraq" uniqKey="Siddiqui I" first="Ishraq" last="Siddiqui">Ishraq Siddiqui</name>
<affiliation>
<inist:fA14 i1="02">
<s1>University of Toronto Scarborough</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zangeneh, Masood" sort="Zangeneh, Masood" uniqKey="Zangeneh M" first="Masood" last="Zangeneh">Masood Zangeneh</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Factor-Inwentash Faculty of Social Work, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Fattah, Abdul" sort="Fattah, Abdul" uniqKey="Fattah A" first="Abdul" last="Fattah">Abdul Fattah</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Awan, Naeem" sort="Awan, Naeem" uniqKey="Awan N" first="Naeem" last="Awan">Naeem Awan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Saad Yousuf, Muhammad" sort="Saad Yousuf, Muhammad" uniqKey="Saad Yousuf M" first="Muhammad" last="Saad Yousuf">Muhammad Saad Yousuf</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>University of Toronto Scarborough</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Psychiatry and clinical neurosciences : (Carlton. Print)</title>
<title level="j" type="abbreviated">Psychiatry clin. neurosci. : (Carlton. Print)</title>
<idno type="ISSN">1323-1316</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Psychiatry and clinical neurosciences : (Carlton. Print)</title>
<title level="j" type="abbreviated">Psychiatry clin. neurosci. : (Carlton. Print)</title>
<idno type="ISSN">1323-1316</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Help seeking</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Psychosis</term>
<term>Treatment</term>
<term>Visual hallucination</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Recherche aide</term>
<term>Traitement</term>
<term>Hallucination visuelle</term>
<term>Maladie de Parkinson</term>
<term>Psychose</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Aim: While much research has been conducted towards understanding the basis of visual hallucinations in Parkinson's disease, little has focused on characterizing the content and patients' emotional experience. These factors are likely very influential on a patient's decision to seek treatment, a critical aspect of any symptom from the clinical perspective. Methods: A retrospective chart analysis was performed on Parkinson's disease patients seen in a community-based Parkinson's Disease and Movement Disorder Clinic between 2005 and 2010. Results: The study consisted of 334 patients with Parkinson's disease, among whom 10.5% had visual hallucinations. Hoehn and Yahr disease stage (P = 0.001), concurrent presence of dementia (P = 0.001), and sex (P = 0.031) were significant onset predictors. The most significant determinant of treatment-seeking was emotional reaction, namely whether hallucinations were bothersome (P = 0.008). However, the specific type of content during hallucinations was sometimes more influential and contradicted emotional response. Conclusion: Although treatment-seeking can be predicted by how individuals feel about hallucinations, a patient's decision may not be logically consistent. We suggest that clinicians offer treatment based on patients' recollections and opinions.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1323-1316</s0>
</fA01>
<fA03 i2="1">
<s0>Psychiatry clin. neurosci. : (Carlton. Print)</s0>
</fA03>
<fA05>
<s2>67</s2>
</fA05>
<fA06>
<s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>QAYYUM RANA (Abdul)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SIDDIQUI (Ishraq)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ZANGENEH (Masood)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>FATTAH (Abdul)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>AWAN (Naeem)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>SAAD YOUSUF (Muhammad)</s1>
</fA11>
<fA14 i1="01">
<s1>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>University of Toronto Scarborough</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Factor-Inwentash Faculty of Social Work, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>509-516</s1>
</fA20>
<fA21>
<s1>2013</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>2312</s2>
<s5>354000504263120060</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>24 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>13-0373166</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Psychiatry and clinical neurosciences : (Carlton. Print)</s0>
</fA64>
<fA66 i1="01">
<s0>AUS</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Aim: While much research has been conducted towards understanding the basis of visual hallucinations in Parkinson's disease, little has focused on characterizing the content and patients' emotional experience. These factors are likely very influential on a patient's decision to seek treatment, a critical aspect of any symptom from the clinical perspective. Methods: A retrospective chart analysis was performed on Parkinson's disease patients seen in a community-based Parkinson's Disease and Movement Disorder Clinic between 2005 and 2010. Results: The study consisted of 334 patients with Parkinson's disease, among whom 10.5% had visual hallucinations. Hoehn and Yahr disease stage (P = 0.001), concurrent presence of dementia (P = 0.001), and sex (P = 0.031) were significant onset predictors. The most significant determinant of treatment-seeking was emotional reaction, namely whether hallucinations were bothersome (P = 0.008). However, the specific type of content during hallucinations was sometimes more influential and contradicted emotional response. Conclusion: Although treatment-seeking can be predicted by how individuals feel about hallucinations, a patient's decision may not be logically consistent. We suggest that clinicians offer treatment based on patients' recollections and opinions.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>770D03M</s0>
<s1>IV</s1>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Recherche aide</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Help seeking</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Busqueda ayuda</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Hallucination visuelle</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Visual hallucination</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Alucinación visual</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Psychose</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Psychosis</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Psicosis</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Homme</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Human</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>18</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>350</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>FRANCIS 13-0373166 INIST</NO>
<ET>Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients</ET>
<AU>QAYYUM RANA (Abdul); SIDDIQUI (Ishraq); ZANGENEH (Masood); FATTAH (Abdul); AWAN (Naeem); SAAD YOUSUF (Muhammad)</AU>
<AF>Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre/Canada (1 aut., 4 aut., 5 aut., 6 aut.); University of Toronto Scarborough/Canada (2 aut., 6 aut.); Factor-Inwentash Faculty of Social Work, University of Toronto/Toronto/Canada (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Psychiatry and clinical neurosciences : (Carlton. Print); ISSN 1323-1316; Australie; Da. 2013; Vol. 67; No. 7; Pp. 509-516; Bibl. 24 ref.</SO>
<LA>Anglais</LA>
<EA>Aim: While much research has been conducted towards understanding the basis of visual hallucinations in Parkinson's disease, little has focused on characterizing the content and patients' emotional experience. These factors are likely very influential on a patient's decision to seek treatment, a critical aspect of any symptom from the clinical perspective. Methods: A retrospective chart analysis was performed on Parkinson's disease patients seen in a community-based Parkinson's Disease and Movement Disorder Clinic between 2005 and 2010. Results: The study consisted of 334 patients with Parkinson's disease, among whom 10.5% had visual hallucinations. Hoehn and Yahr disease stage (P = 0.001), concurrent presence of dementia (P = 0.001), and sex (P = 0.031) were significant onset predictors. The most significant determinant of treatment-seeking was emotional reaction, namely whether hallucinations were bothersome (P = 0.008). However, the specific type of content during hallucinations was sometimes more influential and contradicted emotional response. Conclusion: Although treatment-seeking can be predicted by how individuals feel about hallucinations, a patient's decision may not be logically consistent. We suggest that clinicians offer treatment based on patients' recollections and opinions.</EA>
<CC>770D03M</CC>
<FD>Recherche aide; Traitement; Hallucination visuelle; Maladie de Parkinson; Psychose; Homme</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Pathologie du système nerveux</FG>
<ED>Help seeking; Treatment; Visual hallucination; Parkinson disease; Psychosis; Human</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases</EG>
<SD>Busqueda ayuda; Tratamiento; Alucinación visual; Parkinson enfermedad; Psicosis; Hombre</SD>
<LO>INIST-2312.354000504263120060</LO>
<ID>13-0373166</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000131 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000131 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Francis:13-0373166
   |texte=   Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022